Beating
Canine
Cancer
Backed by science
Led by compassion
Dog Owners
Click below to learn about our new cancer treatments being developed for dogs, how they work, and ways your dog may be able to access them.
Vets
Click below to learn about our investigational medicines for canine cancer patients, including the science, clinical trials and compassionate use.
The challenge
Cancer is one of the leading causes of death in dogs. Current treatment options have major limitations, and many dogs still need better ways to treat their cancer.
Our approach
CaniVax develops new cancer medicines for dogs by translating advances in modern human cancer medicine. Our programmes include both oral cancer drugs and cancer vaccines.
The science
Our work is grounded in cancer biology, genetics and immunology. We use these advances to develop and test new treatments specifically for canine cancer patients.
Contact us for further information and access options.
A science-led approach to canine cancer
Cancer is complex and different cancers require different ways of treating the disease.
CaniVax is developing complementary approaches to canine cancer. Our programmes include oral cancer medicines designed to target tumour biology, alongside cancer vaccines that help the immune system recognise and attack cancer cells.
Our CaniMune™ platform identifies tumour antigens that can be used to develop vaccines for different canine cancers.
Together, these programmes form our broader approach to developing new cancer medicines for dogs.
How We Develop New Cancer Medicines
Cancer Biology
We start by going deep into the biology of canine cancer to understand how tumours grow, survive and interact with the immune system.
Translational Science
We translate advances in cancer biology, genetics and immunology into practical treatment strategies for canine patients.
Modern Technologies
We use the latest drug development process, vaccine technologies and AI tools to turn these discoveries into new cancer medicines.
Clinical Development
We take the most promising treatments into clinical studies to determine whether they can improve outcomes and quality of life for dogs with cancer.
Dogs Deserve Better Cancer Treatment
CaniVax applies rigorous scientific approaches to develop new cancer treatments, working closely with scientists, veterinary professionals and regulatory bodies.
“Our goal is to develop a new generation of canine cancer treatments that give owners better options and improve outcomes for dogs with cancer.”
Latest News
CaniVax™ Announces appointment of Dr Thu Nguyen to lead its canine cancer vaccine programme
OXFORD, UK; 14 July 2026 – CaniVax™ Limited, the leader in developing novel therapeutics to treat canine cancer, has today announced the appointment of Dr Thu Nguyen to lead its canine cancer vaccine programme. Dr Nguyen is a highly experienced…
Cancer Treatment Is Changing. The Immune System Offers New Possibilities.
Cancer treatment is evolving as scientists learn more about the biology of cancer and the immune system. While traditional therapies often focus on directly targeting tumour growth, newer approaches are exploring whether the immune system itself may become part of…
Cancer Leaves a Trail. Science Is Finally Learning to Follow It
Cancer is not invisible to the immune system. The real question is why it is not always recognised. Immunopeptidomics offers a way to look directly at what cancer cells are showing to the immune system, and what may be going…
Contact Us
Dog owners and veterinary professionals can use this form to learn more about CaniVax medicines in development, including potential clinical access and participation in clinical trials.
Tell us briefly about your dog, patient or clinical interest, and we will contact you to discuss the relevant programme and whether an appropriate route may be available.
Submitting this form does not guarantee access to treatment.
Register your interest below:
Photo credit © Adrian Baughan - Oxford Dog Photography.